Pregled bibliografske jedinice broj: 451460
Gastric Pentadecapeptide BPC 157 and Short Bowel Syndrome in Rats
Gastric Pentadecapeptide BPC 157 and Short Bowel Syndrome in Rats // Digestive diseases and sciences, 54 (2009), 10; 2070-2083 doi:10.1007/s10620-008-0598-y (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 451460 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Gastric Pentadecapeptide BPC 157 and Short Bowel Syndrome in Rats
Autori
Sever, Marko ; Kliček, Robert ; Radić, Božo ; Brčić, Luka ; Zoričić, Ivan ; Drmić, Domagoj ; Ivica, Mihovil ; Barišić, Ivan ; Ilić, Spomenko ; Berkopić, Lidija ; Boban Blagaić, Alenka ; Ćorić, Marijana ; Kolenc, Danijela ; Vrčić, Hrvoje ; Anić, Tomislav ; Seiwerth, Sven ; Sikirić, Predrag
Izvornik
Digestive diseases and sciences (0163-2116) 54
(2009), 10;
2070-2083
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
gastric pentadecapeptide BPC 157; short bowel syndrome; rats
Sažetak
The gastric pentadecapeptide BPC 157, which was shown to be safe as an antiulcer peptide in trials for inflammatory bowel disease (PL14736, Pliva), successfully healed intestinal anastomosis and fistula in rat. Therefore, we studied for 4 weeks rats with escalating short bowel syndrome and progressive weight loss after small bowel resection from fourth ileal artery cranially of ileocecal valve to 5 cm beneath pylorus. BPC 157 (10 microg/kg or 10 ng/kg) was given perorally, in drinking water (12 ml/rat/day) or intraperitoneally (once daily, first application 30 min following surgery, last 24 h before sacrifice). Postoperatively, features of increasingly exhausted presentation were: weight loss appearing immediately regardless of villus height, twofold increase in crypt depth and fourfold increase in muscle thickness within the first week, jejunal and ileal overdilation, and disturbed jejunum/ileum relation. In contrast, constant weight gain above preoperative values was observed immediately with BPC 157 therapy, both perorally and parenterally, and villus height, crypt depth, and muscle thickness [inner (circular) muscular layer] also increased, at 7, 14, 21, and 28 days. Moreover, rats treated with pentadecapeptide BPC 157 showed not different jejunal and ileal diameters, constant jejunum-to-ileum ratio, and increased anastomosis breaking strength. In conclusion, pentadecapeptide BPC 157 could be helpful to cure short bowel syndrome.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
108-1083570-3635 - Pentadekapeptid BPC 157 - daljnja istraživanja (Sikirić, Predrag, MZOS ) ( CroRIS)
108-0532264-0048 - Hepatocelularni tumori (Ćorić, Marijana, MZOS ) ( CroRIS)
108-1080321-0389 - Utjecaj pentadekapeptida BPC 157 na ženski urogenitalni sustav (Vrčić, Hrvoje, MZOS ) ( CroRIS)
108-1083570-3636 - Učinak BPC 157 na induciranu bilijarnu opstrukciju (Anić, Tomislav, MZOS ) ( CroRIS)
108-1083570-3643 - Kvantitativna analiza i prijenos slike u patologiji (Seiwerth, Sven, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Spomenko Ilić
(autor)
Sven Seiwerth
(autor)
Hrvoje Vrčić
(autor)
Ivan Zoričić
(autor)
Luka Brčić
(autor)
Robert Kliček
(autor)
Predrag Sikirić
(autor)
Danijela Kolenc
(autor)
Marijana Ćorić
(autor)
Alenka Boban Blagaić
(autor)
Tomislav Anić
(autor)
Marko Sever
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE